The Woodlands, TX, United States of America

Lam: Dominic M

This inventor holds 1 USPTO granted patent. Top assignee: Houston Biotechnology Incorporated. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lam: Dominic M. Retrieved from https://idiyas.com/inventor/lam-dominic-m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Ophthalmic Treatments by Dominic M. Lam

Introduction: Dominic M. Lam is an accomplished inventor based in The Woodlands, TX (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of nerve degeneration. His innovative approaches aim to enhance retinal blood flow, which is crucial for maintaining eye health.

Latest Patents: Lam holds a patent for "Ophthalmic compositions for treating nerve degeneration." This patent outlines methods for improving retinal and choroidal blood flow. The compounds described can be administered either topically or systemically, providing a variety of physiologically acceptable formulations to enhance retinal blood flow.

Career Highlights: Dominic M. Lam is associated with Houston Biotechnology Incorporated, where he applies his expertise in developing advanced ophthalmic treatments. His work focuses on creating effective solutions for patients suffering from retinal issues.

Collaborations: Lam collaborates with George C. Chiou, leveraging their combined knowledge to further advancements in ophthalmic research and treatment methodologies.

Conclusion: Dominic M. Lam's contributions to ophthalmic compositions demonstrate his commitment to improving eye health through innovative treatments. His work continues to pave the way for advancements in the field of ophthalmology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…